The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 20, 2020

Filed:

Nov. 26, 2019
Applicant:

National University of Ireland, Galway, Galway, IE;

Inventors:

David Townley, County Clare, IE;

Brian Shields, Galway, IE;

Ivan Keogh, Galway, IE;

Peter Dockery, Galway, IE;

Ian Stephen O'Brien, Galway, IE;

Martin O'Halloran, Galway, IE;

Emily Elizabeth Porter, Galway, IE;

Marggie Jones, Galway, IE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/04 (2006.01); A61N 1/05 (2006.01); A61B 5/00 (2006.01); A61B 5/053 (2006.01); A61B 18/14 (2006.01); A61N 1/36 (2006.01); A61B 18/02 (2006.01); A61B 18/00 (2006.01); A61N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61N 1/0546 (2013.01); A61B 5/0538 (2013.01); A61B 5/6858 (2013.01); A61B 18/1492 (2013.01); A61N 1/36075 (2013.01); A61N 1/36135 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00327 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00839 (2013.01); A61B 2018/0212 (2013.01); A61N 1/3603 (2017.08); A61N 1/36021 (2013.01); A61N 2007/0021 (2013.01);
Abstract

Devices, systems, and methods for specializing, monitoring, and/or evaluating therapeutic nasal neuromodulation are disclosed herein. A targeted neuromodulation system configured in accordance with embodiments of the present technology can include, for example, an evaluation/modulation assembly at a distal portion of a shaft and including a plurality of electrodes. The electrodes are configured to emit stimulating energy at frequencies for identifying and locating target neural structures and detect the resultant bioelectric properties of the tissue. The system can also include a console that maps locations of the target neural structures. The evaluation/modulation assembly can then apply therapeutic neuromodulation energy in a highly tailored neuromodulation pattern based on the mapped locations of the target neural structures. Accordingly, the system provides therapeutic neuromodulation to highly specific target structures while avoiding non-target structures to reduce collateral effects.


Find Patent Forward Citations

Loading…